Neil Risch

Risch has conducted significant work on the nature of human differences on a geographical scale. For instance, he used social and genetic data to analyse genetic admixture from White, African, and Native American ancestry in Puerto Rico, as well as relating this to geographical variation in social status.

Risch considers that genetic drift is a more compelling explanation for the carrier frequency of lysosomal storage diseases in Ashkenazi Jews than heterozygote advantage, in light of analysis of the results of recent genetic testing by his collaborators and himself.

After mapping torsion dystonia by linkage disequilibrium (LD) analysis he found it was genetically dominant and was a founder mutation. Other work has focused on the genetic basis of Parkinson's disease, hemochromatosis, multiple sclerosis, diabetes, autism, epilepsy and hypertension.

Risch has worked on the genetic structure of human groups, for instance multiple levels of structure above the level of the individual increasing in scale up to the level of race. He has translated these results into theoretical impacts on, for instance, rate of decay of linkage disequilibrium, and practical application in personalised medicine. For instance, using the Framingham data, he showed that population stratification leads not only to fewer heterozygotes than predicted from Hardy-Weinberg equilibrium but also to spouses sharing genotypes at all ancestrally informative markers, accounted for by ancestry-related assortative mating in the previous generation.

In a small twin study on Autism (around 50 twin pairs for each disease and zygosity), he argued these disorders may be less heritable than previously considered, implicating a significant family-level environment effect. Similar findings were observed in family studies

Risch has been a prominent critic of studies on the role of genetics in sexual orientation. In 1999, with colleagues he published a sib-pair study that failed to replicate a previously observed linkage between male sexual orientation and Xq28 DNA markers. While an independent study also found evidence at the same Xq28 location, more recent very large studies failed to produce any evidence of a genetic effect in this region of the X chromosome. Risch also discussed ethical issues underlying studies of socially significant traits and the under-representation of minority scientists in human genetics in his 2015 ASHG Presidential Address, which received a standing ovation.

With his colleague Kathleen Merikangas, Risch is possibly best known for introducing the concept of genome-wide association studies for the discovery and characterization of genetic variants of modest effects underlying complex diseases. That insight revolutionized the field of human genetics, leading to a large number of genome-wide association studies and the discovery of thousands of genetic variants underlying a broad range of diseases and traits.

Risch is also known, with his colleague Catherine Schaefer, for pioneering the linkage of genome-wide genotype data to electronic health records in a large health provider database (at Kaiser Permanente Northern California), which also demonstrated the power of genome-wide association studies on a large scale.

Risch has received numerous awards and recognition for his scholarship. He is an elected fellow of the American Association for the Advancement of Science (2010), the California Academy of Sciences (2011), and a member of the National Academy of Medicine (2010). He was the 2015 President of the American Society of Human Genetics, the 2004 recipient of the Curt Stern Award (now the Scientific Achievement Award) from the American Society of Human Genetics and the 2023 recipient of the Lifetime Achievement Award (formerly the William Allan Award) from the American Society of Human Genetics, to date the only individual to have received both. He was also the 2022 recipient of the Paul Hoch Award from the American Psychopathological Association.